Indiana Laboratory Company Agrees to Pay More Than $9 Million to Settle Alleged False Claims Act Violations
INDIANAPOLIS- Patients Choice Laboratories (“PCL”), a diagnostic laboratory headquartered in Indianapolis, Indiana, has agreed to pay the United States $9,620,000 to resolve allegations that it violated the False Claims Act and the Anti-Kickback Statute (“AKS”). The government alleges that PCL knowingly submitted claims to Medicare for respiratory pathogen panels (“RPPs”) that were either medically unnecessary or obtained through kickbacks. PCL also paid commissions to independent sales representatives and marketing firms (“1099 representatives”) based on the volume or value of referrals.
Action Details
- Date:November 24, 2025
- Agency:U.S. Attorney's Office, Southern District of Indiana
-
Enforcement Types:
- Criminal and Civil Actions